Abstract
(+/-)-3alpha-hydroxy homoepibatidine 4 has been synthesized from the alkaloid scopolamine 5 and its properties as a nicotinic agonist assessed. While still binding strongly, the compound showed reduced agonist potency for the alpha(4)beta(2) nAChR compared with the parent compound epibatidine 1. Compound 4 also displayed generally similar binding and selectivity profiles at alpha(4)beta(2), alpha(2)beta(4), alpha(3)beta(4), and alpha(4)beta(4) nAChR subtypes to those for nicotine.
Originalsprog | Engelsk |
---|---|
Tidsskrift | Bioorganic & Medicinal Chemistry Letters |
Vol/bind | 14 |
Udgave nummer | 1 |
Sider (fra-til) | 271-3 |
Antal sider | 3 |
ISSN | 0960-894X |
Status | Udgivet - 2004 |